CID 13143665

N-(1,2,3-trimethyl-3-pyrazolin-5-ylidene)salicylamide

Structural Information

Molecular Formula
C13H15N3O2
SMILES
CC1=CC(=NC(=O)C2=CC=CC=C2O)N(N1C)C
InChI
InChI=1S/C13H15N3O2/c1-9-8-12(16(3)15(9)2)14-13(18)10-6-4-5-7-11(10)17/h4-8,17H,1-3H3
InChIKey
UJVOYPQGFQAQDS-UHFFFAOYSA-N
Compound name
2-hydroxy-N-(1,2,5-trimethylpyrazol-3-ylidene)benzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

245.11642 Da
Monoisotopic Mass

2.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 246.123696 154.5
[M+Na]+ 268.105638 164.6
[M-H]- 244.109144 159.9
[M+NH4]+ 263.150243 171.4
[M+K]+ 284.079578 161.2
[M+H-H2O]+ 228.113680 146.5
[M+HCOO]- 290.114621 178.2
[M+CH3COO]- 304.130271 195.9
[M+Na-2H]- 266.091086 157.0
[M]+ 245.11587142 156.6
[M]- 245.11696858 156.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.